Eliminate the uncertainty of your future.

There is an increased likelihood of a BRCA1 or BRCA2 mutation in patients with certain personal and family history characteristics and various clinical criteria. BRCANOWis a Next-Gen Sequencing (NGS)-based assay using a state-of-the-art platform to detect whether or not a mutation is present. 

Everyone has BRCA1
and BRCA2 genes .

When mutations occur within these genes, a person’s risk of developing specific cancers such as breast and ovarian cancer increases. A parent who has one of these genetic mutations can pass the mutation along to his or her child, thus increasing the child’s risk of developing cancer associated with the mutation.

BRCA1/2 mutations can be passed or inherited from a mother or a father in an autosomal dominant fashion. This means that having only one copy of a BRCA1/2 mutation can increase your chance of developing certain cancers like breast and ovarian. If your mother or father carries a BRCA mutation, you have a 50% chance of inheriting that same mutation.

About 1 in every 500 women in the United States has a mutation in either her BRCA1 or BRCA2 gene. If either your mother or your father has a BRCA1/2 gene mutation, you have a 50% chance of having the same mutation.

Who is at Risk?

BRCA mutations can occur in both males and females and in any race or ethnic group. The occurrence of mutations in the United States is about 1 in 500. However, for some ethnic groups, such as the Ashkenazi Jewish population, the risk of carrying a BRCA mutation increases to 1 in 40. 

Risk of Cancer in Individuals with a
BRCA1 or BRAC2 Mutation

Cancer Type

General Population
(No Mutation)

BRCA1
Mutation

BRCA2
Mutation

Breast

12%
50-80%
40-70%
Ovarian
1-2%
24-40%
11-18%

We're here to guide you
through the process.

Part of BRCANOW® includes genetic counseling to walk you through our process and test results, along with any lifestyle or treatment alternatives depending on your results. 

Additional Resources